“The International Congress on Hematologic Malignancies offers the latest updates from the advancing field of hematology,” said Talamo. “This educational event is an evolving source for hematology professionals to keep up with latest advancements, attend panel discussions and interact with their peers.”
This educational event is intended for community-based hematologists and medical oncologists, nurse practitioners, nurses, physician assistants, pharmacists and health care professionals interested in the treatment of hematologic malignancies. The case-base format of the event offers an opportunity to the audience to apply their newly gained knowledge in their practice settings to optimize patient outcomes. Attendees will receive the latest information on pressing topics for 2018 including biomarkers in myeloma management, use of Chimeric antigen receptor T cells and other immunotherapeutic strategies in treatment, clinical consideration for follicular lymphoma and novel therapies in acute leukemias. In addition, the meeting will feature a pre-conference workshop on CAR-T cell therapy.
The co-chairs for the event include Jorge Cortes, M.D., Jane and John Justin distinguished chair in leukemia research, chief CML and AML Sections, deputy chair, Department of Leukemia, The University of Texas MD Anderson Cancer Center; Andre Goy, M.D., M.S.,chairman and executive director, Lymphoma Division Chief, John Theurer Cancer Center, chief science officer, Regional Cancer Care Associates, Lydia Pfund chair for lymphoma, professor of medicine, Georgetown University; and Sagar Lonial M.D., FACP, professor, Emory School of Medicine, chair, department of hematology and medical oncology, chief medical officer, Winship Cancer Institute of Emory University.
For additional information and to register, visit www.gotoper.com/conferences/hem/meetings/22nd-International-Congress-on-Hematologic-Malignancies-Focus-on-Leukemias-Lymphomas-and-Myeloma.
Since 1995, Physicians’ Education Resource, LLC® (PER®), has been the leading provider of live and online CME activities on oncology and hematology by providing high-quality, evidence-based activities featuring leading experts who focus on the application of practice-changing advances. In 2018, PER® will develop and implement 20 historic annual legacy conferences in the United States and Europe, along with many world-renowned online learning formats such as Medical Crossfire®. PER is accredited by both the Accreditation Council for Continuing Medical Education (ACCME) and the California Board of Registered Nursing (CBRN). PER® is part of the Cranbury, New Jersey-based Michael J. Hennessy Associates, Inc. family of businesses. Learn more at http://www.gotoper.com and http://www.mjhassoc.com.